Aug 2026· Molecular Carcinogenesis· 0 citations· 61 references
Medicine
TL;DR
Functional knockdown data support an association with endothelial angiogenic phenotypes in LIHC tissues and rescue, in vivo, and independent clinical validation remain required.
Abstract
Liver hepatocellular carcinoma (LIHC) is a molecularly heterogeneous malignancy for which additional genetically supported biomarkers and functional regulators remain to be identified. We aimed to identify candidate genes through integrative genetic and transcriptomic screening, then determine the cellular context and functional relevance of the leading candidate. We applied Summary-data-based Mendelian Randomization to FinnGen LIHC genome-wide association summary statistics and GTEx v8 liver cis-eQTL summary data. A 1000 Genomes European-ancestry panel provided the linkage disequilibrium reference. Candidate genes were cross-referenced with Gene Expression Omnibus differentially expressed genes and TCGA-LIHC prognostic genes. After ATP13A2 emerged from this screen, we used bulk, single-cell, and spatial transcriptomic analyses to characterize its expression and cellular context. HUVEC knockdown, migration, tube formation, qRT-PCR, and Western blotting were then used for functional assessment. ATP13A2 was the only gene shared by the SMR-prioritized, GEO differential-expression, and TCGA-LIHC prognostic sets. ATP13A2 expression was higher in LIHC tissues and independently associated with worse survival in the TCGA-LIHC cohort. Single-cell analysis subsequently localized ATP13A2 predominantly to tumor endothelial cells, and spatial and pathway analyses associated ATP13A2-positive endothelial cells with angiogenic programs and inferred PTN-NCL signaling. In HUVECs, ATP13A2 knockdown reduced migration and tube formation and was accompanied by reduced ERK1/2 and p38 MAPK phosphorylation. An unbiased integrative screen prioritized ATP13A2 as a genetically supported LIHC candidate, after which single-cell analysis identified its tumor-endothelial context. Functional knockdown data support an association with endothelial angiogenic phenotypes. Rescue, in vivo, and independent clinical validation remain required.
Functional data link LINC02163 expression to HCC cell growth, PI3K/AKT pathway activity, and changes in stemness-related markers, although the underlying mechanism remains to be established.
Convergent genetic, transcriptomic, and protein-level evidence prioritizes CDC16 as a GC-associated candidate tissue marker whose expression is closely linked to proliferative activity.
Fan Xue, Dao-Cheng Wu, Xu Zhang· International Journal of Bio...· 0 citations
Hepatocellular carcinoma (HCC) is one of the malignant tumors with high incidence and mortality rates worldwide. Given the poor prognosis of patients with HCC, it is crucial to explore the molecular mechanisms underlying HCC development and to evaluate prognostic markers. Differential expression analysis followed by un...
Yu-Xian Liu, Xing-Jie Chen, Jun-Yuan Zhang et al.· International Journal of Mol...· 0 citations
INTRODUCTION/OBJECTIVE
Endothelial dysfunction and altered stromal-immune crosstalk are implicated in chronic inflammatory diseases. However, their roles in atherosclerotic plaque (AP) and premature ovarian insufficiency (POI) remain unclear.
METHODS
The single-cell RNA-seq (scRNA-seq) data of AP and human follicular...
Qian-Qian Ma, Han Zheng, Ai-Ling Chen et al.· Current Medicinal Chemistry· 0 citations
Background: Hepatocellular carcinoma (HCC) heterogeneity, particularly the presence of tumor cells co-expressing hepatocytic and cholangiocytic markers, contributes to therapeutic resistance and poor prognosis, yet its molecular correlates remain incompletely understood. This study aimed to characterize dual-phenotype...
Jie Zhang, Min-Jun Li, Tai-Xin Yang et al.· Cancers· 0 citations
Pan-cancer analysis establishes WDR76 as a robust pan-cancer prognostic biomarker and a potential immunotherapeutic target and provides experimental evidence that WDR76 functions as an oncogenic driver in liver cancer, promoting malignant phenotypes and offering a novel avenue for targeted therapeutic intervention.
Yi-Fan Wang, Rong Zhou, Shen-Long Guo et al.· International Journal of Imm...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.